Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assocaiton Between Uric Acid Trajecteries and Remission of Non-alcoholic Fatty Liver Disease (NAFLD) in NAFLD Individuals

NCT05245890 is registered in ClinicalTrials.gov with Ningbo No. 1 Hospital as lead sponsor.

NCT NCT05245890
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05245890 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assocaiton Between Uric Acid Trajecteries and Remission of Non-alcoholic Fatty Liver Disease (NAFLD) in NAFLD Individuals
Lead sponsor
Ningbo No. 1 Hospital
Phase
Observational
Overall status
Unknown status
Start date
March 1, 2022
Completion date
March 1, 2024
Enrollment
2,000 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hyperuricemia, non-alcoholic fatty liver disease